Designing an HCV vaccine: a unique convergence of prevention and therapy?
about
Viral persistence, liver disease and host response in Hepatitis C-like virus rat model.Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus.Hepatitis C Vaccines, Antibodies, and T Cells.Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene ExpressionHepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges
P2860
Designing an HCV vaccine: a unique convergence of prevention and therapy?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@en
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@nl
type
label
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@en
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@nl
prefLabel
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@en
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@nl
P2860
P1476
Designing an HCV vaccine: a unique convergence of prevention and therapy?
@en
P2093
Christopher M Walker
P2860
P304
P356
10.1016/J.COVIRO.2017.03.014
P577
2017-04-01T00:00:00Z